Federal Register Notice: FDA’s Advisory Committee for Reproductive Health Drugs will meet 6/17, from 8 a.m. to 4:30 p.m. at the Hilton Washington DC North/Gaithersburg, The Ballrooms, 620 Perry Pkwy., Gaithersburg, MD. Contact Kalyani Bhatt, (301) 827-7001. The committee will discuss Laboratoire HRA Pharma’s NDA for ulipristal acetate tablets, 30 mg, an emergency contraceptive for preventing pregnancy following unprotected intercourse or a known or suspected contraceptive failure. To view this notice, click here.